All articles tagged with #stimulant medications
Originally Published 18 days ago — by PsyPost
A new study reveals that ADHD medications like methylphenidate primarily act on brain networks related to wakefulness and reward, rather than attention control, by enhancing arousal and motivation, and can mask sleep deprivation effects, challenging traditional views of how these drugs work.
Originally Published 18 days ago — by SciTechDaily
A study reveals that ADHD medications like Ritalin and Adderall primarily boost alertness and motivation by affecting brain reward and wakefulness systems, rather than directly improving attention, and may mimic sleep effects, raising concerns about sleep deprivation in diagnosis and treatment.
Originally Published 1 year ago — by Study Finds
A new study suggests that long-term use of stimulant medications like Adderall and Ritalin for ADHD may slightly increase the risk of developing cardiomyopathy, a condition where the heart muscle weakens. While the overall risk remains relatively low, researchers found that patients on stimulants were more likely to develop cardiomyopathy over time compared to those not taking the medications. The study emphasizes the importance of closely monitoring patients on long-term stimulant regimens and watching for potential cardiac symptoms, although experts stress that the risk is still very low and that the benefits of these medications for managing ADHD symptoms often outweigh the potential risks.
Originally Published 2 years ago — by PBS NewsHour
The ongoing nationwide shortage of ADHD medications like Vyvanse, Adderall, and Ritalin is causing significant strain on patients and their families. The shortage, which has been ongoing for over a year, has made it difficult for individuals with ADHD to access the medications they rely on to manage their symptoms. The demand for stimulant medications has increased during the pandemic, but manufacturers have not been able to keep up. This shortage has led to disruptions in daily routines, difficulties in focusing and completing tasks, and emotional regulation issues for those affected. The lack of transparency in drug manufacturing and limited visibility into production quantities has made it challenging to address the shortage effectively.